In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD(+)/NADH redox state
However, when you are taking a prescription medication like semaglutide, it is natural to wonder if you are still eligible to sit in that donor chair
Renal outcomes in type 2 diabetes: a review of cardiovascular and renal outcome trials
It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]
This popularity is transforming the pharmaceutical landscape and driving innovation in adjacent sectors such as medical devices, wellness tech, and digital health, which has led to an influx of investment by companies looking to capitalize on this rising trend